Our findings uncover a new mechanism by which LTF may interact with LRP1 to inhibit metastatic progression in ccRCC and also reveal the therapeutic value of recombinant LTF protein in treating metastatic ccRCC. The gene discussed is LRP1; the disease is nonpapillary renal cell carcinoma.